VISTAGEN THERAPEUTICS, INC. Interest Receivable
VISTAGEN THERAPEUTICS, INC. (VTGN) had Interest Receivable of $2.00 thousand as of 2014-09-30, per its 10-Q filed 2014-11-19.
Discontinued › Balance Sheet › Assets
us-gaap:InterestReceivable · last filed 2015-06-29
- 2014-09-30: Interest Receivable $2.00K.
- 2014-06-30: Interest Receivable $5.30K.
- 2014-03-31: Interest Receivable $2.80K.
- 2013-12-31: Interest Receivable $2.80K; Interest Receivable as first filed $400.00.
| Period end | Interest Receivable | Interest Receivable as first filed |
|---|---|---|
| 2014-09-30 | $2.00K 10-Q · filed 2014-11-19 | |
| 2014-06-30 | $5.30K 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $2.80K 10-K · filed 2015-06-29 | |
| 2013-12-31 | $2.80K 10-Q · filed 2015-02-17 | $400.00 10-Q · filed 2014-02-14 |
| 2013-09-30 | $2.80K 10-Q · filed 2014-11-19 | $2.10K 10-Q · filed 2013-11-14 |
| 2013-06-30 | $2.80K 10-Q · filed 2014-08-12 | |
| 2012-03-31 | $1.60K 10-K · filed 2014-06-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |